Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Macroinvertebrate Responses to Conductivity in Different Bioregions of Victoria, Australia.

Shackleton M, Holland A, Stitz L, McInerney P.

Environ Toxicol Chem. 2019 Jun;38(6):1334-1342. doi: 10.1002/etc.4400. Epub 2019 May 9.

PMID:
30790341
2.

A thermostable messenger RNA based vaccine against rabies.

Stitz L, Vogel A, Schnee M, Voss D, Rauch S, Mutzke T, Ketterer T, Kramps T, Petsch B.

PLoS Negl Trop Dis. 2017 Dec 7;11(12):e0006108. doi: 10.1371/journal.pntd.0006108. eCollection 2017 Dec.

3.

Response of macroinvertebrate communities to seasonal hydrologic changes in three sub-tropical Australian streams.

Stitz L, Fabbro L, Kinnear S.

Environ Monit Assess. 2017 Jun;189(6):254. doi: 10.1007/s10661-017-5957-8. Epub 2017 May 5.

PMID:
28477274
4.

An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs.

Schnee M, Vogel AB, Voss D, Petsch B, Baumhof P, Kramps T, Stitz L.

PLoS Negl Trop Dis. 2016 Jun 23;10(6):e0004746. doi: 10.1371/journal.pntd.0004746. eCollection 2016 Jun.

5.

The Priority position paper: Protecting Europe's food chain from prions.

Requena JR, Kristensson K, Korth C, Zurzolo C, Simmons M, Aguilar-Calvo P, Aguzzi A, Andreoletti O, Benestad SL, Böhm R, Brown K, Calgua B, Del Río JA, Espinosa JC, Girones R, Godsave S, Hoelzle LE, Knittler MR, Kuhn F, Legname G, Laeven P, Mabbott N, Mitrova E, Müller-Schiffmann A, Nuvolone M, Peters PJ, Raeber A, Roth K, Schmitz M, Schroeder B, Sonati T, Stitz L, Taraboulos A, Torres JM, Yan ZX, Zerr I.

Prion. 2016 May 3;10(3):165-81. doi: 10.1080/19336896.2016.1175801.

6.

Correction: Aerosols transmit prions to immunocompetent and immunodeficient mice.

Haybaeck J, Heikenwalder M, Klevenz B, Schwarz P, Margalith I, Bridel C, Mertz K, Zirdum E, Petsch B, Fuchs TJ, Stitz L, Aguzzi A.

PLoS Pathog. 2016 Feb 12;12(2):e1005463. doi: 10.1371/journal.ppat.1005463. eCollection 2016 Feb. No abstract available.

7.

Structural organization of mammalian prions as probed by limited proteolysis.

Vázquez-Fernández E, Alonso J, Pastrana MA, Ramos A, Stitz L, Vidal E, Dynin I, Petsch B, Silva CJ, Requena JR.

PLoS One. 2012;7(11):e50111. doi: 10.1371/journal.pone.0050111. Epub 2012 Nov 20.

8.

Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection.

Petsch B, Schnee M, Vogel AB, Lange E, Hoffmann B, Voss D, Schlake T, Thess A, Kallen KJ, Stitz L, Kramps T.

Nat Biotechnol. 2012 Dec;30(12):1210-6. doi: 10.1038/nbt.2436. Epub 2012 Nov 25.

PMID:
23159882
9.

Cellular prion protein participates in amyloid-β transcytosis across the blood-brain barrier.

Pflanzner T, Petsch B, André-Dohmen B, Müller-Schiffmann A, Tschickardt S, Weggen S, Stitz L, Korth C, Pietrzik CU.

J Cereb Blood Flow Metab. 2012 Apr;32(4):628-32. doi: 10.1038/jcbfm.2012.7. Epub 2012 Feb 1.

10.

Aerosols: an underestimated vehicle for transmission of prion diseases?

Stitz L, Aguzzi A.

Prion. 2011 Jul-Sep;5(3):138-41. doi: 10.4161/pri.5.3.16851. Epub 2011 Jul 1. Review.

11.

Biological effects and use of PrPSc- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions.

Petsch B, Müller-Schiffmann A, Lehle A, Zirdum E, Prikulis I, Kuhn F, Raeber AJ, Ironside JW, Korth C, Stitz L.

J Virol. 2011 May;85(9):4538-46. doi: 10.1128/JVI.02467-10. Epub 2011 Feb 23.

12.

Aerosols transmit prions to immunocompetent and immunodeficient mice.

Haybaeck J, Heikenwalder M, Klevenz B, Schwarz P, Margalith I, Bridel C, Mertz K, Zirdum E, Petsch B, Fuchs TJ, Stitz L, Aguzzi A.

PLoS Pathog. 2011 Jan 13;7(1):e1001257. doi: 10.1371/journal.ppat.1001257. Erratum in: PLoS Pathog. 2016 Feb;12(2):e1005463.

13.

Genetic dissection of interferon-antagonistic functions of rabies virus phosphoprotein: inhibition of interferon regulatory factor 3 activation is important for pathogenicity.

Rieder M, Brzózka K, Pfaller CK, Cox JH, Stitz L, Conzelmann KK.

J Virol. 2011 Jan;85(2):842-52. doi: 10.1128/JVI.01427-10. Epub 2010 Nov 17. Erratum in: J Virol. 2012 Apr;86(8):4720.

14.

The alternative NF-kappaB signalling pathway is a prerequisite for an appropriate immune response against lymphocytic choriomeningitis virus infection.

Droebner K, Klein B, Paxian S, Schmid R, Stitz L, Planz O.

Viral Immunol. 2010 Jun;23(3):295-308. doi: 10.1089/vim.2009.0101.

PMID:
20565293
15.

Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling.

Hu W, Nessler S, Hemmer B, Eagar TN, Kane LP, Leliveld SR, Müller-Schiffmann A, Gocke AR, Lovett-Racke A, Ben LH, Hussain RZ, Breil A, Elliott JL, Puttaparthi K, Cravens PD, Singh MP, Petsch B, Stitz L, Racke MK, Korth C, Stüve O.

Brain. 2010 Feb;133(Pt 2):375-88. doi: 10.1093/brain/awp298. Epub 2010 Feb 9.

16.

Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma.

Miller J, Eisele G, Tabatabai G, Aulwurm S, von Kürthy G, Stitz L, Roth P, Weller M.

J Neurosurg. 2010 Aug;113(2):280-5. doi: 10.3171/2009.11.JNS09901.

PMID:
19961309
17.

Structure-activity relationship of tocopherol derivatives suggesting a novel non-antioxidant mechanism in antiprion potency.

Muyrers J, Klingenstein R, Stitz L, Korth C.

Neurosci Lett. 2010 Jan 18;469(1):122-6. doi: 10.1016/j.neulet.2009.11.057. Epub 2009 Nov 27.

PMID:
19945507
18.

De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis.

Sigurdson CJ, Nilsson KP, Hornemann S, Heikenwalder M, Manco G, Schwarz P, Ott D, Rülicke T, Liberski PP, Julius C, Falsig J, Stitz L, Wüthrich K, Aguzzi A.

Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):304-9. doi: 10.1073/pnas.0810680105. Epub 2008 Dec 10.

19.

Attenuation of rabies virus replication and virulence by picornavirus internal ribosome entry site elements.

Marschalek A, Finke S, Schwemmle M, Mayer D, Heimrich B, Stitz L, Conzelmann KK.

J Virol. 2009 Feb;83(4):1911-9. doi: 10.1128/JVI.02055-08. Epub 2008 Dec 10.

20.

Complementarity determining regions of an anti-prion protein scFv fragment orchestrate conformation specificity and antiprion activity.

Müller-Schiffmann A, Petsch B, Leliveld SR, Muyrers J, Salwierz A, Mangels C, Schwarzinger S, Riesner D, Stitz L, Korth C.

Mol Immunol. 2009 Feb;46(4):532-40. doi: 10.1016/j.molimm.2008.07.023. Epub 2008 Oct 30.

PMID:
18973947
21.

Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.

Leliveld SR, Stitz L, Korth C.

Biochemistry. 2008 Jun 10;47(23):6267-78. doi: 10.1021/bi800253c. Epub 2008 May 13.

PMID:
18473442
22.

[Native and renatured oligomer-dependent epitopes of intracellular influenza virus nucleocapsid protein].

Semenova NP, Prokudina EN, Chumakov VM, Grigor'eva TA, Stitz L.

Vopr Virusol. 2008 Jan-Feb;53(1):21-4. Russian.

PMID:
18318130
23.

An antigenic epitope of influenza virus nucleoprotein (NP) associated with polymeric forms of NP.

Prokudina EN, Semenova N, Chumakov V, Stitz L.

Virol J. 2008 Feb 29;5:37. doi: 10.1186/1743-422X-5-37.

24.

Influence of water, fat, and glycerol on the mechanism of thermal prion inactivation.

Müller H, Stitz L, Wille H, Prusiner SB, Riesner D.

J Biol Chem. 2007 Dec 7;282(49):35855-67. Epub 2007 Sep 18.

25.

Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA.

Scheel B, Aulwurm S, Probst J, Stitz L, Hoerr I, Rammensee HG, Weller M, Pascolo S.

Eur J Immunol. 2006 Oct;36(10):2807-16.

26.

The expanded octarepeat domain selectively binds prions and disrupts homomeric prion protein interactions.

Leliveld SR, Dame RT, Wuite GJ, Stitz L, Korth C.

J Biol Chem. 2006 Feb 10;281(6):3268-75. Epub 2005 Dec 13.

28.

Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice.

Olschläger V, Pleschka S, Fischer T, Rziha HJ, Wurzer W, Stitz L, Rapp UR, Ludwig S, Planz O.

Oncogene. 2004 Aug 26;23(39):6639-46.

PMID:
15235583
29.
30.
31.

Borna disease virus nucleoprotein interacts with the CDC2-cyclin B1 complex.

Planz O, Pleschka S, Oesterle K, Berberich-Siebelt F, Ehrhardt C, Stitz L, Ludwig S.

J Virol. 2003 Oct;77(20):11186-92.

33.

Precursors of Borna disease virus-specific T cells in secondary lymphatic tissue of experimentally infected rats.

Batra A, Planz O, Bilzer T, Stitz L.

J Neurovirol. 2003 Jun;9(3):325-35.

PMID:
12775416
34.

Genetic relationship of Borna disease virus isolates.

Planz O, Rziha HJ, Stitz L.

Virus Genes. 2003 Jan;26(1):25-30.

PMID:
12680690
35.

The immunopathogenesis of Borna disease virus infection.

Stitz L, Bilzer T, Planz O.

Front Biosci. 2002 Feb 1;7:d541-55. Review.

PMID:
11815301
36.

Cortical cholinergic decline parallels the progression of Borna virus encephalitis.

Gies U, Görcs TJ, Mulder J, Planz O, Stitz L, Bilzer T, Luiten PG, Harkany T.

Neuroreport. 2001 Dec 4;12(17):3767-72.

PMID:
11726791
38.

A naturally processed rat major histocompatibility complex class I-associated viral peptide as target structure of borna disease virus-specific CD8+ T cells.

Planz O, Dumrese T, Hulpusch S, Schirle M, Stevanovic S, Stitz L.

J Biol Chem. 2001 Apr 27;276(17):13689-94. Epub 2001 Jan 25.

40.

Bornavirus isolates of human origin.

Planz O, Rziha HJ, Stitz L.

Lancet. 2000 Feb 19;355(9204):656-7. No abstract available.

PMID:
10697008
41.
42.

Borna disease virus nucleoprotein (p40) is a major target for CD8(+)-T-cell-mediated immune response.

Planz O, Stitz L.

J Virol. 1999 Feb;73(2):1715-8. Erratum in: J Virol 1999 May;73(5):4530.

43.

A functional role for neutralizing antibodies in Borna disease: influence on virus tropism outside the central nervous system.

Stitz L, Nöske K, Planz O, Furrer E, Lipkin WI, Bilzer T.

J Virol. 1998 Nov;72(11):8884-92.

44.

Persistence of Borna disease virus-specific nucleic acid in blood of psychiatric patient.

Planz O, Rentzsch C, Batra A, Rziha HJ, Stitz L.

Lancet. 1998 Aug 22;352(9128):623. No abstract available.

PMID:
9746029
45.

Lack of antiviral effect of amantadine in Borna disease virus infection.

Stitz L, Planz O, Bilzer T.

Med Microbiol Immunol. 1998 Mar;186(4):195-200.

PMID:
9574902
46.
47.

Borna disease virus-induced neurological disorder in mice: infection of neonates results in immunopathology.

Hallensleben W, Schwemmle M, Hausmann J, Stitz L, Volk B, Pagenstecher A, Staeheli P.

J Virol. 1998 May;72(5):4379-86.

48.

Disturbance of the cortical cholinergic innervation in Borna disease prior to encephalitis.

Gies U, Bilzer T, Stitz L, Staiger JF.

Brain Pathol. 1998 Jan;8(1):39-48.

PMID:
9458165
49.

No Borna disease virus-specific RNA detected in blood from psychiatric patients in different regions of Germany. The Bornavirus Study Group.

Lieb K, Hallensleben W, Czygan M, Stitz L, Staeheli P.

Lancet. 1997 Oct 4;350(9083):1002. No abstract available.

PMID:
9329518

Supplemental Content

Support Center